NCT04713527

Brief Summary

Patients diagnosed with acute appendicitis receives antibiotics during the operation, and only patients where the surgeon suspects a complicated appendicitis with spread inflammation to the abdominal cavity receive antibiotics for 3 days postoperative. In a previous study at the surgical department, the investigators were able to show that the surgeon's assessment during the surgery of whether the appendicitis are complicated or not is very uncertain. This means that some patients receive antibiotics after surgery for no reason, and others might have benefited from antibiotics. The aim of this study is to solve this problem. By extracting some of the peritoneal fluid, it is possible to investigate whether there are bacteria or not in the abdominal cavity. Today when the fluid is cultivated, the answer will appear after 3-4 days. Therefore a new method is needed which confirms the presence of bacteria in the abdominal cavity within 24 hours. In this study growth of bacteria in cultivation is examined and determined within 24 hours. The study also want to use PCR analysis. It is a special technique, which examines the fluid from the abdominal cavity for bacteria and provide answer within a few hours. It is investigated whether it is possible to perform this method in the daily routine of the department. New research also shows that if patients needs antibiotics after surgery they can be treated with tablets instead of injection into the blood vessel. Antibiotic treatment with tablets will mean that the patient can be discharged earlier. The primary purpose of this study is to investigate whether it is possible with the PCR technique or cultivation to determine whether there are bacteria in the abdominal cavity of patients undergoing surgery for acute appendicitis or not, so that any continued antibiotic treatment after surgery can be targeted to the individual patient. The secondary purpose is to investigate whether antibiotic treatment with tablets are as effective as getting antibiotics into the blood vessel. The patients participating in the project will undergo the usual routine treatment and surgery. The only exception is retrieval of the naturally occurring fluid from the abdominal cavity. This will be done during the operation by special suction equipment that can be fitted to the usual operating equipment. It will not cause any discomfort or inconvenience to the patient. The technique of extracting fluid from the abdominal cavity has been used in previous studies of patients operated on for acute appendicitis. The benefit for the patient will be a more targeted antibiotic treatment so that both unnecessary treatment is avoided, and patients who previously would not have received treatment can benefit from this. For society a more targeted antibiotic treatment will mean less risk of developing resistance and less hospitalization.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 2, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 19, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2021

Completed
Last Updated

May 5, 2021

Status Verified

January 1, 2021

Enrollment Period

11 months

First QC Date

November 2, 2020

Last Update Submit

May 4, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Cultivation answer within 24 hours

    A sample of peritoneal fluid is observed for growth of bacteria in Department of Clinical Microbiology within 24 hours after surgery. The answer is either positive (growth of bacteria) or negative (no growth of bacteria).

    24 hours after surgery

  • PCR answer within 24 hours

    A sample of peritoneal fluid is analysed with the PCR-method. The outcome is either positive (detection of bacterial DNA) or negative (no detection of bacterial DNA)

    24 hours after surgery

  • Complications

    Wound infection, intraabdominal abscess and other

    30 days follow up

Secondary Outcomes (7)

  • Descriptive data - sex

    1 day

  • Descriptive data - height

    1 day

  • Descrriptive data - weight

    1 day

  • Descriptive data - American Society of Anesthesiologists (ASA) score

    1 day

  • Descriptive data - smoking status

    1 day

  • +2 more secondary outcomes

Interventions

During operation for appendicitis peritoneal fluid will be extracted. This is sent to cultivation and PCR analysis to determine if there is bacteria within the peritoneal cavity.

Patients with complicated appendicitis will receive enteral antibiotics instead of intravenous

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Admitted by the Emergency Department (FAM), at OUH or Svendborg

You may qualify if:

  • Patients undergoing diagnostic laparoscopy with suspected acute appendicitis
  • Admitted by the Emergency Department (FAM), at Odense University Hospital (OUH) or Svendborg
  • Gets a laparoscopic appendectomy.
  • Speaks and understands Danish

You may not qualify if:

  • Age under 18
  • Pregnant or breastfeeding
  • Language difficulties
  • Sepsis preoperatively assessed via the SIRS criteria leading to preoperatively administered antibiotics.
  • Patients with known gastrointestinal disorders as chronic inflammatory bowel disease or previous cancer disease.
  • Open appendectomy
  • Other illness than acute appendicitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital, OUH

Odense, 5000, Denmark

RECRUITING

Related Publications (7)

  • Bhangu A, Soreide K, Di Saverio S, Assarsson JH, Drake FT. Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management. Lancet. 2015 Sep 26;386(10000):1278-1287. doi: 10.1016/S0140-6736(15)00275-5.

    PMID: 26460662BACKGROUND
  • Daskalakis K, Juhlin C, Pahlman L. The use of pre- or postoperative antibiotics in surgery for appendicitis: a systematic review. Scand J Surg. 2014 Mar;103(1):14-20. doi: 10.1177/1457496913497433. Epub 2013 Sep 20.

    PMID: 24056131BACKGROUND
  • van Rossem CC, Schreinemacher MH, Treskes K, van Hogezand RM, van Geloven AA. Duration of antibiotic treatment after appendicectomy for acute complicated appendicitis. Br J Surg. 2014 May;101(6):715-9. doi: 10.1002/bjs.9481. Epub 2014 Mar 26.

    PMID: 24668341BACKGROUND
  • Tind S, Qvist N. Acute Appendicitis: A Weak Concordance Between Perioperative Diagnosis, Pathology and Peritoneal Fluid Cultivation. World J Surg. 2017 Jan;41(1):70-74. doi: 10.1007/s00268-016-3686-8.

    PMID: 27541029BACKGROUND
  • Kleif J, Rasmussen L, Fonnes S, Tibaek P, Daoud A, Lund H, Gogenur I. Enteral Antibiotics are Non-inferior to Intravenous Antibiotics After Complicated Appendicitis in Adults: A Retrospective Multicentre Non-inferiority Study. World J Surg. 2017 Nov;41(11):2706-2714. doi: 10.1007/s00268-017-4076-6.

    PMID: 28600695BACKGROUND
  • National Collaborating Centre for Women's and Children's Health (UK). Surgical Site Infection: Prevention and Treatment of Surgical Site Infection. London: RCOG Press; 2008 Oct. Available from http://www.ncbi.nlm.nih.gov/books/NBK53731/

    PMID: 21698848BACKGROUND
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.

    PMID: 15273542BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Peritoneal Fluid.

MeSH Terms

Conditions

Appendicitis

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal Diseases

Central Study Contacts

Regitze DS Sørensen, Stud. med.

CONTACT

Niels Qvist, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2020

First Posted

January 19, 2021

Study Start

June 22, 2020

Primary Completion

May 29, 2021

Study Completion

June 28, 2021

Last Updated

May 5, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations